Survival of patients with metastatic melanoma and brain metastases in the era of MAP-kinase inhibitors and immunologic checkpoint blockade antibodies: a …

F Spagnolo, V Picasso, M Lambertini, V Ottaviano… - Cancer treatment …, 2016 - Elsevier
Background The incidence of brain metastases (BM) in melanoma patients is common and
associated with poor prognosis. MAP-kinase inhibitors and immunologic checkpoint …
被引用次数：85 相关文章

Survival of patients with metastatic melanoma and brain metastases in the era of MAP-kinase inhibitors and immunologic checkpoint blockade antibodies: A …

F Spagnolo, V Picasso… - Cancer …, 2016 - cancertreatmentreviews.com
Background The incidence of brain metastases (BM) in melanoma patients is common and
associated with poor prognosis. MAP-kinase inhibitors and immunologic checkpoint …

[引用][C] Survival of patients with metastatic melanoma and brain metastases in the era of MAP-kinase inhibitors and immunologic checkpoint blockade antibodies: A …

F Spagnolo, V Picasso, M Lambertini… - Cancer Treatment …, 2016 - cir.nii.ac.jp
Survival of patients with metastatic melanoma and brain metastases in the era of MAP-kinase
inhibitors and immunologic checkpoint blockade antibodies: A systematic review | CiNii …

Survival of patients with metastatic melanoma and brain metastases in the era of MAP-kinase inhibitors and immunologic checkpoint blockade antibodies: A …

F Spagnolo, V Picasso, M Lambertini… - Cancer Treatment …, 2016 - infona.pl
The incidence of brain metastases (BM) in melanoma patients is common and associated
with poor prognosis. MAP-kinase inhibitors and immunologic checkpoint blockade …

Survival of patients with metastatic melanoma and brain metastases in the era of MAP-kinase inhibitors and immunologic checkpoint blockade antibodies: A …

F Spagnolo, V Picasso, M Lambertini… - Cancer treatment …, 2016 - pubmed.ncbi.nlm.nih.gov
Background The incidence of brain metastases (BM) in melanoma patients is common and
associated with poor prognosis. MAP-kinase inhibitors and immunologic checkpoint …

Survival of patients with metastatic melanoma and brain metastases in the era of MAP-kinase inhibitors and immunologic checkpoint blockade antibodies: A …

F Spagnolo, V Picasso, M Lambertini… - Cancer Treatment …, 2016 - europepmc.org
Background The incidence of brain metastases (BM) in melanoma patients is common and
associated with poor prognosis. MAP-kinase inhibitors and immunologic checkpoint …